Your browser doesn't support javascript.
loading
Clinical Outcomes of Chemotherapy Naïve Men with Metastatic Castration Resistant Prostate Cancer and Low Baseline Prostate Specific Antigen Treated with Enzalutamide vs Placebo.
Taplin, Mary-Ellen; Armstrong, Andrew J; Lin, Ping; Krivoshik, Andrew; Phung, De; Parli, Teresa; Tombal, Bertrand; Beer, Tomasz M.
Afiliação
  • Taplin ME; Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: Mary_Taplin@dfci.harvard.edu.
  • Armstrong AJ; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina.
  • Lin P; Medivation, San Francisco, California.
  • Krivoshik A; Astellas Pharma Global Development, Northbrook, Illinois.
  • Phung; Astellas Pharma Global Development, Northbrook, Illinois.
  • Parli T; Medivation, San Francisco, California.
  • Tombal B; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Beer TM; Oregon Health & Science University Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.
J Urol ; 198(6): 1324-1332, 2017 12.
Article em En | MEDLINE | ID: mdl-28736322
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Antígeno Prostático Específico / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article